MORE►
treatment
NanOlogy Chief Medical Officer Gere DiZerega at far left speaking at 2019 BIO CEO and Investor Conference. [Video still: NanOlogy]
Fort Worth Biotech NanOlogy Gets U.S. Patent for New Cancer Treatment
by Lance Murray | Mar 7, 2023
NanOlogy said the new patent covers a method of treating cancer by intratumoral administration of large surface area microparticle taxanes in combination with systemic administration of immune checkpoint inhibitors. “The goal is to identify which combinations can increase the immune response, thereby increasing the overall solid tumor response to treatment," said NanOlogy Chief Medical Officer Gere DiZerega.
by Lance Murray |
Mar 2, 2023
The FDA approval is not only a first for Reata's treatment of ultra-rare disease Friedreich's Ataxia. It's a first in the company's history, reports FiercePharma. On the news, Reata’s stock skyrocketed nearly 200% Wednesday, according to the Dallas Morning News, which cited an estimate that the drug will create a revenue stream in excess of $1 billion.
MORE►
by Alex Edwards |
Oct 13, 2020
Neuro Rehab VR's new XR Therapy, a portable system that's clinically validated and FDA registered, is being lauded as the first virtual reality system for neurological rehabilitation and physical therapy treatment.
MORE►
by Alex Edwards |
Sep 24, 2020
Using alternating magnetic fields in technology created by UTSW researchers, Solenic Medical aims to provide a better way to treat prosthetic joint infections than the current standard of care. Recently, the startup received an FDA designation of a Breakthrough Device.
MORE►
Rosy CEO and Founder Lyndsey Harper [Photo: Michael Samples; illustration: Natty Blissful via iStock]
Rosy Launches ‘First-Ever’ Telehealth Program to Connect Women With Intimacy Issues to Healthcare Providers
by Riley Farrell | Jun 16, 2020
Dallas-based Rosy's telehealth service connects Texas women to a network of licensed medical and mental health providers specializing in the treatment of women’s sexual health concerns.
MORE►
by Lance Murray |
Jan 31, 2020
In this weekly roundup of research and development activity in North Texas, you'll also find out about DART receiving a federal grant to help in the fight against human trafficking.
MORE►
by Lance Murray |
Nov 15, 2019
In this weekly roundup of research and development activity in North Texas, you’ll also find news on UTSW and the American Heart Association examining cardiac concerns, as well as Cook Children’s in Fort Worth receiving a grant to bolster research.
MORE►
by Lance Murray |
Nov 1, 2019
Also in this weekly roundup of research and development news, you’ll find out how $500,000 in grants is helping a UTA research team study bridges’ effects on stream ecology and safety during floods.
MORE►
[Photo by Nitro100 via iStock]
R&D: No Pleasure in Life—SMU Scientists Test Treatment; UTSW Studies Hepatitis C & Liver Cancer
by Lance Murray | Jan 25, 2019
You’ll also find out about how research at the University of Texas at Dallas may help determine who is at high risk for Alzheimer’s disease in this roundup of research and development activity in North Texas.
MORE►
by Lance Murray |
Sep 14, 2018
You'll also discover how scientists at the UNT Health Science Center turned an honored discovery in 1998 into another award and a possible Glaucoma treatment.
MORE►
by Lance Murray |
May 11, 2018
Plus, a local researcher is looking at how media coverage affects public perception of the court system. Find out more in the weekly roundup of research and development in Dallas-Fort Worth.
MORE►
by Lance Murray |
Sep 13, 2017
The technique uses "naked" nanoparticles that can be injected directly into a tumor for greater efficacy and safety.
MORE►
A 3D image of a heart. [Photo Courtesy Children's Health]
3-D Heart Imaging Helps Diagnose, Treat Children
by Nicholas Sakelaris | Mar 6, 2017
The technology gives families a better understanding of their child’s condition and assists physicians in planning treatment.
MORE►
by Lance Murray |
Dec 21, 2016
The company as developed a treatment for presbyopia, which can make it difficult for people to focus their eyes.
MORE►
by Nealie Sanchez |
Sep 23, 2016
The researchers hope to develop treatments that could be used months, maybe even years, after a stroke.
MORE►
